SCHEMBL31140239

SCHEMBL31140239

c1cncc(-c2cnccn2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 10/20 0.67
CYP3A4 P08684 4/20 0.61
ALDH1A1 P00352 3/20 0.61
CYP1A2 P05177 2/20 0.61
HSP90AA1 P07900 1/20 0.53
HSP90AB1 P08238 1/20 0.53
PTK2 Q05397 1/20 0.53
LOXL2 Q9Y4K0 1/20 0.53
KDM4E B2RXH2 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CYP19A1 P11511 2/20 0.52
METAP2 P50579 1/20 0.52
SIRT3 Q9NTG7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672073 1.00 CYP2A6 (0.67) CYP2A6CYP3A4ALDH1A1CYP1A2HSP90AA1
SCHEMBL13989118 0.86 CYP2A6 (0.56) CYP2A6CYP3A4ALDH1A1CYP1A2LOXL2
Pivalate SCHEMBL27910502 0.84 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2LMNA
SCHEMBL29904375 0.84 CYP2A6 (0.52) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL166615 0.84 CYP2A6 (0.52) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL6997058 0.84 CYP2A6 (0.57) CYP2A6CYP3A4ALDH1A1CYP1A2HSP90AA1
SCHEMBL28165095 0.84 CYP2A6 (0.57) CYP2A6CYP3A4ALDH1A1CYP1A2HSP90AA1
SCHEMBL9974994 0.83 CYP2A6 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2LOXL2
Pyridine SCHEMBL28875197 0.83 CYP2A6 (0.57) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
Hydrochloric Acid SCHEMBL4552312 0.82 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240335442-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS UNIVERSIDADE FEDERAL DO RIO DE JANEIRO – UFRJ (BR) 2024-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240335442-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS SCN1A, SCN7A, SCN8A CYP2A6 1128/4885CYP3A4 1340/4885ALDH1A1 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.